(Q33499861)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230150%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Hemorrhagic complications of intravenous heparin use (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230150%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230150%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

C P Juergens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230150%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C Semsarian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230150%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A C Keech

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230150%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P J Harris

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230150%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230150%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230150%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230150%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230150%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

150-154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230150%20AND%20SRC:MED&resulttype=core&format=json

Hemorrhagic complications of anticoagulant therapy

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Aspirin, heparin, or both to treat acute unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Haemorrhagic complications of heparin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Management of heparin therapy: Controlled prospective trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Control of Heparin Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Heparin therapy: a randomized prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Heparin therapy in thromboembolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Efficacy and Toxicity of Heparin in Relation to Age and Sex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

A prospective study of the incidence and natural history of femoral vascular complications after percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Predictors of bleeding during heparin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

The Hazards of Aspirin plus Heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

Heparin doses and major bleedings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900309-3

10.1016/S0002-9149(97)00309-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230150%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference